Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Authors of this article:

Yuanchao Ma^{1, 2, 3, 4} ;   Sofiane Achiche¹ ;   Marie-Pascale Pomey^{5, 6, 7} ;   Jesseca Paquette⁵ ;   Nesrine Adjtoutah^{5, 6} ;   Serge Vicente^{2, 3, 8, 9} ;   Kim Engler^{2, 3} ;   MARVIN chatbots MARVIN chatbots Patient Expert Committee^{2, 10} ;   Moustafa Laymouna^{2, 3, 8} ;   David Lessard^{2, 3, 4} ;   Benoît Lemire⁴ ;   Jamil Asselah¹¹ ;   Rachel Therrien⁵ ;   Esli Osmanlliu^{2, 12} ;   Ma'n H Zawati¹³ ;   Yann Joly¹³ ;   Bertrand Lebouché^{2, 3, 4, 8}